Updated analysis on polypharmacy and mortality from the ESTHER study
Eur J Clin Pharmacol
.
2018 Jul;74(7):981-982.
doi: 10.1007/s00228-018-2445-1.
Epub 2018 Apr 6.
Authors
Ben Schöttker
1
2
3
,
Dana Clarissa Muhlack
4
5
,
Liesa Katharina Hoppe
4
5
,
Bernd Holleczek
6
,
Hermann Brenner
4
5
Affiliations
1
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. b.schoettker@dkfz-heidelberg.des.
2
Network Aging Research, University of Heidelberg, Heidelberg, Germany. b.schoettker@dkfz-heidelberg.des.
3
Institute of Health Care and Social Sciences, FOM University, Essen, Germany. b.schoettker@dkfz-heidelberg.des.
4
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
5
Network Aging Research, University of Heidelberg, Heidelberg, Germany.
6
Saarland Cancer Registry, Saarbrücken, Germany.
PMID:
29623360
DOI:
10.1007/s00228-018-2445-1
No abstract available
Publication types
Letter
MeSH terms
Aged
Female
Follow-Up Studies
Humans
Male
Mortality*
Polypharmacy*
Time Factors
Grants and funding
01GY1320A/Bundesministerium für Bildung und Forschung